Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Buy
67
BKNIY Quote, Financials, Valuation and Earnings
Last price:
$12.97
Seasonality move
:
-2.25%
Day range:
$12.85 - $13.01
52-week range:
$7.41 - $13.48
Dividend yield:
4.37%
P/E ratio:
10.88x
P/S ratio:
3.60x
P/B ratio:
1.78x
Volume:
283.2K
Avg. volume:
28.1K
1-year change:
46.22%
Market cap:
$11.7B
Revenue:
$3.3B
EPS (TTM):
$1.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.4B | $2.4B | $3.2B | $3.3B | |
| Revenue Growth (YoY) | 6.87% | 12.17% | 0.7% | 32.22% | 5.76% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $310.6M | $315M | $307.4M | $337.8M | $359.6M | |
| Other Inc / (Exp) | $58.1M | $65.6M | $55.1M | $27.5M | $28.2M | |
| Operating Expenses | $1.3B | $1.3B | $1.2B | $1.4B | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $263.3M | $635M | $827.9M | $1.3B | $1.5B | |
| Earnings of Discontinued Ops. | $163.3M | $1.1B | -- | -- | -- | |
| Income Tax Expense | $64.4M | $164.8M | $237.1M | $415.8M | $440.2M | |
| Net Income to Company | $362.2M | $1.6B | $590.8M | $914.6M | $1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $362.2M | $1.6B | $590.8M | $914.6M | $1B | |
| Basic EPS (Cont. Ops) | $0.40 | $1.76 | $0.65 | $1.02 | $1.15 | |
| Diluted EPS (Cont. Ops) | $0.38 | $1.73 | $0.64 | $0.99 | $1.11 | |
| Weighted Average Basic Share | $898.6M | $898.9M | $898.9M | $898.9M | $898.9M | |
| Weighted Average Diluted Share | $903.5M | $898.9M | $898.9M | $898.9M | $898.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $421.7M | $837.4M | $1.1B | $2.9B | $3.8B | |
| Revenue (Reported) | $2.1B | $2.4B | $2.4B | $3.2B | $3.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $421.7M | $837.4M | $1.1B | $2.9B | $3.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $568.2M | $565.3M | $752.2M | $833.2M | $783.8M | |
| Revenue Growth (YoY) | 17.89% | -0.52% | 33.07% | 10.76% | -5.93% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $110.2M | $104.2M | $105M | $113.1M | $117.3M | |
| Other Inc / (Exp) | $33.5M | $36.5M | $17M | -- | -- | |
| Operating Expenses | $307M | $276.1M | $361.7M | $394.4M | $321.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $193.6M | $240.4M | $316.2M | $354.8M | $398.2M | |
| Earnings of Discontinued Ops. | $38.5M | -- | -- | -- | -- | |
| Income Tax Expense | $53.3M | $67.3M | $117.8M | $136.7M | $113.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $178.7M | $173.1M | $198.4M | $218.1M | $284.2M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.19 | $0.21 | $0.23 | $0.31 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.19 | $0.21 | $0.23 | $0.31 | |
| Weighted Average Basic Share | $926.7M | $898.6M | $898.6M | $956.2M | $931.5M | |
| Weighted Average Diluted Share | $926.7M | $898.6M | $898.6M | $956.2M | $931.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $240.6M | $295.2M | $524.5M | $900.7M | $880.4M | |
| Revenue (Reported) | $568.2M | $565.3M | $752.2M | $833.2M | $783.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $240.6M | $295.2M | $524.5M | $900.7M | $880.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.4B | $2.5B | $3.2B | $3.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $405M | $397.5M | $388.6M | $434.7M | $454.5M | |
| Other Inc / (Exp) | $118.9M | $78.5M | $49.5M | $21.7M | $15M | |
| Operating Expenses | $1.4B | $1.4B | $1.4B | $1.5B | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $306.5M | $683.9M | $903.2M | $1.4B | $1.5B | |
| Earnings of Discontinued Ops. | $170.2M | $1.1B | -- | -- | -- | |
| Income Tax Expense | $75.9M | $180M | $287.2M | $434.8M | $418.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $400.8M | $1.6B | $616M | $935.3M | $1.1B | |
| Basic EPS (Cont. Ops) | $0.44 | $1.78 | $0.68 | $1.04 | $1.23 | |
| Diluted EPS (Cont. Ops) | $0.43 | $1.76 | $0.68 | $1.02 | $1.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $470.7M | $893.6M | $1.3B | $3.3B | $3.7B | |
| Revenue (Reported) | $2.2B | $2.4B | $2.5B | $3.2B | $3.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $470.7M | $893.6M | $1.3B | $3.3B | $3.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $568.2M | $565.3M | $752.2M | $833.2M | $783.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $110.2M | $104.2M | $105M | $113.1M | $117.3M | |
| Other Inc / (Exp) | $33.5M | $36.5M | $17M | -- | -- | |
| Operating Expenses | $307M | $276.1M | $361.7M | $394.4M | $321.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $193.6M | $240.4M | $316.2M | $354.8M | $398.2M | |
| Earnings of Discontinued Ops. | $38.5M | -- | -- | -- | -- | |
| Income Tax Expense | $53.3M | $67.3M | $117.8M | $136.7M | $113.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $178.7M | $173.1M | $198.4M | $218.1M | $284.2M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.19 | $0.21 | $0.23 | $0.31 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.19 | $0.21 | $0.23 | $0.31 | |
| Weighted Average Basic Share | $926.7M | $898.6M | $898.6M | $956.2M | $931.5M | |
| Weighted Average Diluted Share | $926.7M | $898.6M | $898.6M | $956.2M | $931.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $240.6M | $295.2M | $524.5M | $900.7M | $880.4M | |
| Revenue (Reported) | $568.2M | $565.3M | $752.2M | $833.2M | $783.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $240.6M | $295.2M | $524.5M | $900.7M | $880.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $19.8B | $27.2B | $16.7B | $17.8B | $18.7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $21.7B | $28.5B | $19.9B | $23B | $25.5B | |
| Property Plant And Equipment | $559.7M | $510M | $480.3M | $468.9M | $460.5M | |
| Long-Term Investments | $14B | $13.3B | $15.7B | $16.2B | $19.4B | |
| Goodwill | $2.8M | $2.6M | $2.4M | $2.5M | $2.4M | |
| Other Intangibles | $314.6M | $302.8M | $296.7M | $331.3M | $331.1M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $118.4B | $121.8B | $115.3B | $124.9B | $126.9B | |
| Accounts Payable | $402.7M | $359.6M | $720.5M | $786.3M | $485.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.2B | $1.3B | $1.6B | $1.7B | $1.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $112.3B | $116.3B | $110B | $119B | $120.8B | |
| Common Stock | $331.7M | $305.3M | $289.2M | $298.1M | $280.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $6.1B | $5.5B | $5.3B | $5.9B | $6.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6.1B | $5.5B | $5.3B | $5.9B | $6.1B | |
| Total Liabilities and Equity | $118.4B | $121.8B | $115.3B | $124.9B | $126.9B | |
| Cash and Short Terms | $19.8B | $27.2B | $16.7B | $17.8B | $18.7B | |
| Total Debt | $9.3B | $8.8B | $8.4B | $10.5B | $10.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $20.3B | $25.3B | $14.4B | $10.7B | $12.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $21.3B | $26.3B | $15.6B | $12B | $14B | |
| Property Plant And Equipment | $537.9M | $495.2M | $481.5M | $461.5M | $483M | |
| Long-Term Investments | $17.9B | $17.1B | $17.6B | $19.4B | $22.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $118.2B | $123.7B | $115.5B | $122B | $134B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $508.3M | $512.6M | $718.9M | $1B | $1.4B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $112.3B | $118.2B | $110.1B | $116.1B | $127.5B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.9B | $5.4B | $5.4B | $5.9B | $6.5B | |
| Total Liabilities and Equity | $118.2B | $123.7B | $115.5B | $122B | $134B | |
| Cash and Short Terms | $20.3B | $25.3B | $14.4B | $10.7B | $12.5B | |
| Total Debt | $8.8B | $8.4B | $7.5B | $8.7B | $10B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $362.2M | $1.6B | $590.8M | $914.6M | $1B | |
| Depreciation & Amoritzation | $86.3M | $92M | $84.5M | $88.8M | $94.7M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.8B | $8.3B | -$8.5B | $712.8M | $2.1B | |
| Capital Expenditures | $99M | $79.7M | $76.2M | $97.8M | $163.5M | |
| Cash Acquisitions | $260.4K | -$63.7M | -$26.3M | -$52.1M | -- | |
| Cash From Investing | -$138M | -$75.6M | -$246.8M | -$47.9M | -$130.7M | |
| Dividends Paid (Ex Special Dividend) | -$100.2M | -$249.4M | -$266.3M | -$439.4M | -$500.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $399.7M | $887.4M | -- | $324.8M | $216.5M | |
| Long-Term Debt Repaid | -$45.7M | -$236.6M | -$527.3M | -- | -- | |
| Repurchase of Common Stock | -$67.4M | -$57.8M | -$89.1M | -$85.7M | -$85.2M | |
| Other Financing Activities | -- | -- | -- | -- | $1.1K | |
| Cash From Financing | $251M | $404.5M | -$793.9M | -$114.5M | -$284M | |
| Beginning Cash (CF) | $7.3B | $17.8B | $23.6B | $14.5B | $664.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.9B | $8.7B | -$9.5B | $550.4M | $1.7B | |
| Ending Cash (CF) | $17.2B | $26.5B | $14.1B | $15B | $666.1B | |
| Levered Free Cash Flow | $9.7B | $8.3B | -$8.5B | $615M | $1.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $48M | $35.6M | $28.5M | $37.4M | $43.5M | |
| Cash Acquisitions | -- | -$65.4M | -$15.3M | -$2.3M | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$96.6M | -$53.9M | -$127M | -$177.7M | -$212.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get BKNIY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BKNIY
Sector
P/E ratio
10.88x
11.67x
PEG ratio
0.63x
0.39x
P/B ratio
1.78x
1.05x
Price / LTM sales
3.60x
2.53x
Growth Metrics
BKNIY
Sector
Revenue growth
-5.93%
5.04%
Earnings growth
33.78%
2.87%
Revenue (5-year growth)
11.04%
5.18%
Earnings forecast
--
$0.56
Profitability
BKNIY
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
6.98%
5.3%
Return on assets
0.86%
0.97%
Return on equity
17.6%
9.25%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Jul
24
Balance Sheet
BKNIY
Sector
Total cash
$12.5B
$470.2M
Short term investments
--
$233.7M
Total assets
$126.9B
$4B
Long term debt
$10B
$296.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
